期刊文献+

重组痘苗病毒载体研究进展 被引量:5

Progress on Recombinant Vaccinia virus Vector
下载PDF
导出
摘要 通过同源重组将外源基因插入到痘苗病毒基因组内,以痘苗病毒为载体使外源基因在动物细胞内表达以获得目的蛋白,从而达到免疫接种的目的。痘苗病毒有宿主范围广、允许插入外源基因片段长、可通过多种途径进行接种、能诱导体液和细胞免疫反应及易于增殖生产等优点,在疫苗研制中得到了广泛的应用。以痘苗病毒作为载体表达狂犬病病毒糖蛋白研制成的狂犬病疫苗已经在野生动物狂犬病控制中发挥了巨大的作用,用痘苗病毒研制的艾滋病病毒疫苗也已经进入了临床试验。 Foreign gene fragment can be inserted into vaccinia virus genome, by homologous recombination, and the virus vector enables the foreign gene to be expressed in mammalian cells. Since the recombiant vaccinia virus has the advantages of wide host rage, permission for large amounts of foreign DNA to be inserted (at least 25 kb) and ease of manufacture and administration, vaccinia virus has become a popular expression vector. Rcombinant vaccinia rabies vaccine has play an important part in eliminating rabies in Western Europe and, more recently, in the United States, and some recombinant HIV vaccines are currently in clinical trials.
出处 《动物医学进展》 CSCD 北大核心 2009年第1期57-61,共5页 Progress In Veterinary Medicine
关键词 重组痘苗病毒 活载体疫苗 应用 recombinant vaccinia virus live vaccine vecter application
  • 相关文献

参考文献25

  • 1Merchlinsky M, Moss B. Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation:recombination-independent selectable cloning vectors[J]. Virology, 1992, 190 (1):522-526.
  • 2Mackett M, Smith G L, Moss B. Vaceinia virus: a seleetable eukaryotic cloning and expression vector[J]. Proc Natl Acad Sci USA, 1982,79:7415-7419.
  • 3Brochier B, Aubert M F, Pastoret P P, et al. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and NorthAmeriea[J]. RevSciTech, 1996, 15 (3):947-1970.
  • 4James H S,Ellen G S. Viruses and human disease[M].北京:科学出版社,2006:223-227.
  • 5Mark R, Buller L, Gregory J P. Poxvirus pathogenesis [J]. Microbiol Rev, 1991, 55(1) :80-122.
  • 6Steven S B. Vaccinia virus transcription [J]. J Gen Virol, 2003,84 : 2293-2303.
  • 7王文玲,黄保英,邓瑶,王秀平,谭文杰,阮力.甲3型流感病毒M2基因在痘苗病毒天坛株中的表达[J].病毒学报,2007,23(5):377-383. 被引量:10
  • 8Christina J K, Janiee C, Matthew R ,et al. Use of reeombiant poxviruses to stimulate anti-melanoma T Cell reaetivity[J]. Annu Surg Oncol,1998,5(1) : 64-76.
  • 9Merehlinsky M, Eckert D, Smith E. Construction and characterization of vaccinia direct ligation vectors[J]. Virology,1997,238:444-451.
  • 10Carroll M W,Moss B. Poxviruses as expression vectors[J]. Curr Opin Biotech, 1997, (8) : 573-577.

二级参考文献23

  • 1李仁清,鲁宁,邓瑶,王文玲,辛伟,张相民,阮力.流感病毒RNA聚合酶蛋白PB1在小鼠中可诱导亚型间交叉免疫保护[J].中华微生物学和免疫学杂志,2006,26(4):322-327. 被引量:2
  • 2Ito T, Gorman O T, Kawaoka Y. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins [J]. J Virol, 1991, 65(10):5491- 5498.
  • 3Black R A, Rota P A, Gorodkova N, et al. Antibody response of the M2 protein of influenza A virus expressed in insect cells[J]. J GenVirol, 1993, 74:143-146.
  • 4Treanor J J, Tierney E L, Zebedee S L, et al. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice [J]. J Virol, 1990, 64:1375-1377.
  • 5Jegerlehner A, Schmitz N, Storni T, et al. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity[J]. J Immunol, 2004, 172(9):5598-5605.
  • 6Okuda K, Ihata A, Watabe S, et al. Protection immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene[J]. Emerg Infect Dis,2007,13(3) :426-435.
  • 7Heinen P P, Rihsewijk F A, de Boer-Luijtze E A, et al. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus [J]. J Gen Virol,2002,83(8) : 1851-1859.
  • 8Mark T S,Zhao Z S,Lo C Y, et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1 [J]. Emerg Infect Dis,2007,13(3):426- 435.
  • 9Mozdaanowska K, Feng J Q, Eid M, et al. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2[J]. Vaccine, 2003, 21:2616-2626.
  • 10Fan J ,Liang X P,Melanie S,et al. Preclinical study of influenza A M2 peptide conjugate vaccines in mice,ferrets, and rhesus monkey[J]. Vaccine, 2004,22 : 2993-3003.

共引文献9

同被引文献70

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部